Dilantin 30 mg Extended Release Oral Capsule
RxNorm 855871
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 855871 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Dilantin 30 mg Extended Release Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PSNPrescribable
Prescribable Name (PSN):
Dilantin 30 mg Extended Release Oral Capsule
(Atom ID: 6371871)
SYPrescribable
Synonym (SY):
Dilantin 30 mg Extended Release Oral Capsule
(Atom ID: 6358199)
SYPrescribable
Synonym (SY):
DPH sodium 30 mg Extended Release Oral Capsule [Dilantin]
(Atom ID: 6358198)
SBDPrescribable
Semantic Branded Drug (SBD):
Phenytoin sodium 30 mg Extended Release Oral Capsule [Dilantin]
(Atom ID: 12370784)
Patient Education
Phenytoin
Phenytoin is used to control certain type of seizures, and to treat and prevent seizures that may begin during or after surgery to the brain or nervous system. Phenytoin is in a class of medications called anticonvulsants. It works by decreasing abnormal electrical activity in the brain.
[Learn More]
* Please review the disclaimer below.